Narcolepsy clinical trials at UCSF
1 in progress, 0 open to eligible people
 Showing  trials for         
- ALKS 2680 in Subjects With Narcolepsy Type 2- Sorry, in progress, not accepting new patients - The purpose of this study is to measure the safety and decrease in sleepiness in subjects with narcolepsy type 2 (NT2) when taking ALKS 2680 tablets compared to placebo tablets. - San Francisco 5391959, California 5332921 and other locations 
Last updated: